These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 25865682)

  • 1. Glypican-3 as a specific biomarker for hepatocellular carcinoma.
    Yao M; Pan LH; Yao DF
    Hepatobiliary Pancreat Dis Int; 2015 Apr; 14(2):122-3. PubMed ID: 25865682
    [No Abstract]   [Full Text] [Related]  

  • 2. Up-regulation of glypican-3 in human hepatocellular carcinoma.
    Suzuki M; Sugimoto K; Tanaka J; Tameda M; Inagaki Y; Kusagawa S; Nojiri K; Beppu T; Yoneda K; Yamamoto N; Ito M; Yoneda M; Uchida K; Takase K; Shiraki K
    Anticancer Res; 2010 Dec; 30(12):5055-61. PubMed ID: 21187490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glypican-3 is a prognostic factor and an immunotherapeutic target in hepatocellular carcinoma.
    Haruyama Y; Kataoka H
    World J Gastroenterol; 2016 Jan; 22(1):275-83. PubMed ID: 26755876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Values of circulating GPC-3 mRNA and alpha-fetoprotein in detecting patients with hepatocellular carcinoma.
    Yao M; Yao DF; Bian YZ; Wu W; Yan XD; Yu DD; Qiu LW; Yang JL; Zhang HJ; Sai WL; Chen J
    Hepatobiliary Pancreat Dis Int; 2013 Apr; 12(2):171-9. PubMed ID: 23558072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel, rapid, and sensitive homogeneous sandwich detection method of Glypican-3 as a serum marker for hepatocellular carcinoma.
    Han N; Wang W; Lu D; Wang H; Ma X; Fan X; Li F
    Chem Commun (Camb); 2017 Nov; 53(90):12209-12212. PubMed ID: 29077109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the Clinical Utility of Glypican 3 as a Serum Marker for the Diagnosis of Hepatocellular Carcinoma.
    Jia X; Gao Y; Zhai D; Liu J; Cai J; Wang Y; Jing L; Du Z
    Technol Cancer Res Treat; 2016 Dec; 15(6):780-786. PubMed ID: 26370140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High preoperative levels of serum glypican-3 containing N-terminal subunit are associated with poor prognosis in patients with hepatocellular carcinoma after partial hepatectomy.
    Haruyama Y; Yorita K; Yamaguchi T; Kitajima S; Amano J; Ohtomo T; Ohno A; Kondo K; Kataoka H
    Int J Cancer; 2015 Oct; 137(7):1643-51. PubMed ID: 25784484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery and diagnostic value of a novel oncofetal protein: glypican 3.
    Wang SK; Zynger DL; Hes O; Yang XJ
    Adv Anat Pathol; 2014 Nov; 21(6):450-60. PubMed ID: 25299314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glypican-3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment.
    Zhou F; Shang W; Yu X; Tian J
    Med Res Rev; 2018 Mar; 38(2):741-767. PubMed ID: 28621802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can serum glypican-3 be a biomarker for effective diagnosis of hepatocellular carcinoma? A meta-analysis of the literature.
    Yang SL; Fang X; Huang ZZ; Liu XJ; Xiong ZF; Liu P; Yao HY; Li CH
    Dis Markers; 2014; 2014():127831. PubMed ID: 25378766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can Glypican3 be diagnostic for early hepatocellular carcinoma among Egyptian patients?
    Abdelgawad IA; Mossallam GI; Radwan NH; Elzawahry HM; Elhifnawy NM
    Asian Pac J Cancer Prev; 2013; 14(12):7345-9. PubMed ID: 24460300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Assessment of serum GPC3 as a tumor marker for hepatocellular carcinoma and malignant melanoma].
    Komori H; Beppu T; Baba H; Nakatsura T; Nishimura Y
    Nihon Rinsho; 2010 Jul; 68 Suppl 7():833-6. PubMed ID: 20960882
    [No Abstract]   [Full Text] [Related]  

  • 13. Diagnosis accuracy of serum Glypican-3 level in patients with hepatocellular carcinoma and liver cirrhosis: a meta-analysis.
    Liu JW; Zuo XL; Wang S
    Eur Rev Med Pharmacol Sci; 2015 Oct; 19(19):3655-73. PubMed ID: 26502856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glypican-3 as a serum marker for hepatocellular carcinoma.
    Capurro M; Filmus J
    Cancer Res; 2005 Jan; 65(1):372; author reply 372-3. PubMed ID: 15665316
    [No Abstract]   [Full Text] [Related]  

  • 15. [Expression of glypican-3 mRNA in hepatocellular carcinoma and its significance].
    Ban KC; Cao J; Ou C; Yang C; Su JJ; Li Y; Xue HF; Duan XX
    Zhonghua Gan Zang Bing Za Zhi; 2005 Apr; 13(4):281, 285. PubMed ID: 15850517
    [No Abstract]   [Full Text] [Related]  

  • 16. Significance of combined tests of serum golgi glycoprotein 73 and other biomarkers in diagnosis of small primary hepatocellular carcinoma.
    Zhao Y; Wang M; Cui C; Zhang L; Liao F; Li H; Wu X
    Cancer Biomark; 2015; 15(5):677-83. PubMed ID: 26406957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic accuracy of serum glypican-3 for hepatocellular carcinoma: a systematic review and meta-analysis.
    Liu XF; Hu ZD; Liu XC; Cao Y; Ding CM; Hu CJ
    Clin Biochem; 2014 Feb; 47(3):196-200. PubMed ID: 24362268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncofetal antigen glypican-3 as a promising early diagnostic marker for hepatocellular carcinoma.
    Yao M; Yao DF; Bian YZ; Zhang CG; Qiu LW; Wu W; Sai WL; Yang JL; Zhang HJ
    Hepatobiliary Pancreat Dis Int; 2011 Jun; 10(3):289-94. PubMed ID: 21669573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a competitive radioimmunoassay for glypican-3 and the clinical application in diagnosis of hepatocellular carcinoma.
    Zhang Q; Xiao Q; Lin Z; Ying X; Li Z; Lin JM
    Clin Biochem; 2010 Aug; 43(12):1003-8. PubMed ID: 20444424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GPC-HCC model: a combination of glybican-3 with other routine parameters improves the diagnostic efficacy in hepatocellular carcinoma.
    Attallah AM; El-Far M; Omran MM; Abdelrazek MA; Attallah AA; Saeed AM; Farid K
    Tumour Biol; 2016 Sep; 37(9):12571-12577. PubMed ID: 27380057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.